CD95 ligand expression as a criterion of malignant transformation in breast cancer -: Reply

被引：0
|
作者：
Müllauer, L [1 ]
机构：
[1] Univ Vienna, Inst Clin Pathol, Vienna, Austria
来源：
JOURNAL OF PATHOLOGY | 2000年 / 191卷 / 04期
关键词：
D O I：
10.1002/1096-9896(200008)191:4<469::AID-PATH646>3.0.CO;2-L
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [31] CD95 ligand in graft rejection
    Nature, 6567 (682):
  • [32] Fas antigen (CD95) expression on peripheral blood lymphocytes in women with breast cancer
    Adamski, JH
    Schaefer, PA
    Gelfand, BJ
    Dias, C
    Shaftan, GW
    FASEB JOURNAL, 2002, 16 (04): : A668 - A668
  • [33] Expression of CD95 ligand in melanocytic lesions as a prognostic marker.
    Maeda, A
    Aragane, Y
    Amatsu, A
    Tezuka, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 570 - 570
  • [34] Demonstration of the expression of CD95 ligand transcript and protein in human placenta
    Zorzi, W
    Thellin, O
    Coumans, B
    Melot, F
    Hennen, G
    Lakaye, B
    Igout, A
    Heinen, E
    PLACENTA, 1998, 19 (04) : 269 - 277
  • [35] CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa
    Grassmé, H
    Kirschnek, S
    Riethmueller, J
    Riehle, A
    von Kürthy, G
    Lang, F
    Weller, M
    Gulbins, E
    SCIENCE, 2000, 290 (5491) : 527 - 530
  • [36] CD95 and Fas ligand expression and apoptosis in rheumatoid arthritis.
    Cantwell, MJ
    Hua, T
    Zvaifler, NJ
    Kipps, TJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 287 - 287
  • [37] Soluble forms of CD95 and CD95 ligand after living related liver transplantation
    Seino, K
    Kayagaki, N
    Yamaguchi, N
    Takada, Y
    Uyama, S
    Kiuchi, T
    Tanaka, K
    Yagita, H
    Okumura, K
    Fukao, K
    TRANSPLANTATION, 1999, 67 (04) : 634 - 636
  • [38] Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis
    Schmidt, M
    Lügering, N
    Lügering, A
    Pauels, HG
    Schulze-Osthoff, K
    Domschke, W
    Kucharzik, T
    JOURNAL OF IMMUNOLOGY, 2001, 166 (02): : 1344 - 1351
  • [39] Inhibition of the alloantibody response by CD95 ligand
    Arai, H
    Chan, SY
    Bishop, DK
    Nabel, GJ
    NATURE MEDICINE, 1997, 3 (08) : 843 - 848
  • [40] CD95/Fas ligand induced toxicity
    Haluck-Kangas, Ashley
    Peter, Marcus E.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2023, 51 (01) : 21 - 29
12345